Your browser doesn't support javascript.
loading
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity.
Wang, Ying; Ertl, Carolin; Schmitt, Christina; Hammann, Linda; Kramer, Rafaela; Grabmaier, Ulrich; Schöberl, Florian; Anz, David; Piseddu, Ignazio; Pesch, Giulia; Vera, Julio; Froehlich, Waltraud; Weckbach, Ludwig; Tomsitz, Dirk; Loquai, Carmen; Zimmer, Lisa; Mangana, Johanna; Dummer, Reinhard; Gutzmer, Ralf; Klespe, Kai-Christian; Stege, Henner; Meiss, Frank; Thoms, Kai-Martin; Terheyden, Patrick; Bröckelmann, Paul J; Johnson, Douglas B; French, Lars E; Heinzerling, Lucie.
Afiliação
  • Wang Y; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Ertl C; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Schmitt C; SERIO Registry, Munich, Germany.
  • Hammann L; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Kramer R; Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Grabmaier U; Department of Dermatology, Friedrich-Alexander University Erlangen-Nürnberg (FAU) and University Hospital Erlangen (UKER), Deutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC-ER-EMN), Erlangen, Germany.
  • Schöberl F; Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany.
  • Anz D; Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Piseddu I; German Center for Vertigo and Balance Disorders (DSGZ), LMU University Hospital, LMU Munich, Munich, Germany.
  • Pesch G; Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Vera J; Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.
  • Froehlich W; Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Weckbach L; Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.
  • Tomsitz D; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Loquai C; Department of Dermatology, Friedrich-Alexander University Erlangen-Nürnberg (FAU) and University Hospital Erlangen (UKER), Deutsches Zentrum Immuntherapie (DZI) and Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nürnberg (CCC-ER-EMN), Erlangen, Germany.
  • Zimmer L; Division of Clinical Pharmacology, Klinikum der Universität München, Munich, Germany.
  • Mangana J; Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany.
  • Dummer R; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Gutzmer R; Department of Dermatology, Klinikum Bremen-Ost, Gesundheit Nord gGmbH, Bremen, Germany.
  • Klespe KC; Department of Dermatology, University Hospital Essen & German Cancer Consortium (DKTK), Partner Site Essen/Duesseldorf, & National Center for Tumor Diseases (NCT)-West, Campus Essen, & Research Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany.
  • Stege H; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Meiss F; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Thoms KM; Department of Dermatology, Johannes Wesling Medical Center, Mühlenkreiskliniken (MKK), Ruhr University Bochum, Minden, Germany.
  • Terheyden P; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
  • Bröckelmann PJ; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Johnson DB; Faculty of Medicine, Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany.
  • French LE; Department of Dermatology, University Medical Center Goettingen, Georg-August-University, Goettingen, Germany.
  • Heinzerling L; Department of Dermatology, University of Lübeck, Lübeck, Germany.
Front Cardiovasc Med ; 11: 1408586, 2024.
Article em En | MEDLINE | ID: mdl-38915743
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha